Navigation Links
Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009

Founder of Leader In LESS Instrumentation Is Selected for Industry Leader LESS Panel at Cleveland Clinic Medical Innovation Summit

FRAMINGHAM, Mass., Jan. 29 /PRNewswire/ -- Cambridge Endo, a pioneer in the rapidly emerging LESS (also called Single Port Access Laparoscopic Surgery or SPA) market, is pleased to announce that its president and founder, Woojin Lee, was among the industry leaders selected to be on a LESS panel at the Cleveland Clinic Medical Innovation Summit. Cambridge Endo developed, manufactures and markets the innovative Autonomy(TM) Laparo-Angle(TM) articulating instruments which, it believes, is the enabling technology that will drive the rapid uptake of this major advance in laparoscopic surgery.

In traditional laparoscopic surgery, the surgeon makes three to six "keyhole" incisions in multiple sites, inserts instrumentation into each "keyhole" and performs the surgery. In LESS/SPA, only one incision is made through the umbilicus (navel). All of the instruments go through this single "keyhole." Said Lee, "LESS/SPA has been called 'scarless' surgery."

According to the Cleveland Clinic, the key criteria used in selecting LESS/SPA as one of the top 10, "game changing" innovations of 2009 were:

  • "Have significant potential for short-term clinical impact (either a major improvement in patient benefit or an improved function that enhances healthcare delivery)
  • Have a high probability of success
  • Be on the market or close to being introduced
  • Have sufficient data available to support its nomination."

Inderbir S. Gill, M.D., Chairman of Urology at the Cleveland Clinic commented, "[we] performed LESS live-donor nephrectomies in nine consecutive kidney donors for kidney transplantation. All aspects of kidney harvesting were completed though the navel. Instead of a visible six-inch scar and a six-week recovery period, patients recovered within two weeks and had a tiny scar hidden by their belly button. Because it only uses one port with multiple channels for the surgeon to simultaneously pass various surgical instruments, LESS may also reduce complications that might occur after traditional open and even laparoscopic abdominal surgery. My patients report less discomfort and have faster recoveries compared to those undergoing traditional laparoscopy." According to the clinic, the return to work time for single port surgery donors is about 17 days vs. 51 for traditional multi-incision laparoscopic procedures.

Commented Lee, "Donor nephrectomy is but one of the many laparoscopic surgical procedures that, we believe, will be converting to LESS/SPA in the coming years. Already, LESS/SPA procedures have been performed with Autonomy articulating instruments in many general, urologic, and gynecologic surgical procedures. Together, over two million of these procedures are currently performed laparoscopically in the U.S. each year. This is a very large addressable market."

About Cambridge Endo

Cambridge Endo is a privately held medical device company that designs, develops and manufactures innovative articulating laparoscopic instruments. The Autonomy(TM) Lapro-Angle(TM) product line is designed to be an enabling technology for LESS/SPA. Autonomy articulating instruments are also used in many traditional laparoscopic procedures by general, bariatric, urologic, and gynecologic surgeons.

Cambridge Endo is headquartered in Framingham, MA. For more information about Cambridge, please visit

    Woojin Lee, Ph.D.
    508-405-0790 ext. 104

SOURCE Cambridge Endo
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
2. Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009
3. Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009
4. NanoMedicine Summit Returns to Cleveland, September 25-26
5. University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
6. Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded
7. Siemens Signs Multi-Year Agreement With Cleveland Clinic to Deploy Enterprise-Wide Cardiology PACS
8. Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007
9. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
10. Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials
11. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier ... that it has been selected by The Michael J. ... cell lines to academic, pharmaceutical, and biotechnology organizations committed ... the United States , and more ... the United States , and more ...
(Date:10/8/2015)... Texas , Oct. 8, 2015 The 2015 ... of The University of Texas at Dallas. Aziz Sancar ... UT Dallas in 1977, is one of ... how cells continuously monitor and repair damaged DNA on a molecular ... in molecular and cell biology from UT Dallas ...
(Date:10/8/2015)... ST. LOUIS , Oct. 8, 2015 /PRNewswire/ ... that the Cerilliant ® brand within its ... its new bile acid reference standards product line ... the most routinely tested bile acids and their ... materials (CRMs) consist of lithocholic acid, taurocholic acid ...
(Date:10/7/2015)... , Oct. 7, 2015 Boston Scientific ... start of the Boston Scientific Connected Patient Challenge ... in the use of remote patient monitoring to enhance ... and entrepreneurs can submit their ideas and collaborate on ... ). Cambridge, MA ...
Breaking Biology Technology:
... 2011 At the White House today, President Barack ... U.S. recipients of the 2010 Kavli Prizes to recognize ... for which the Prizes are awarded -- astrophysics, nanoscience ... Joined by the President,s science advisor, John ...
... Kingdom, June 6, 2011 Oxford BioMedicaplc ... gene therapy company, today announces that it has signed ... biotechnology company specialising in the development of engineered antibody ... engineer an in vivo diagnostic imaging agent ...
... Biosciences, a leading innovator in protein diagnostics, announces ... allows researchers to cost effectively accelerate their research ... Avantra,s proven QPDx™ BioChip platform. The QPDx™ platform ... using catalog or custom reagents. Avantra,s ...
Cached Biology Technology:
(Date:9/10/2015)... , Sept. 10, 2015 Report Details ... far not quite delivered upon previous expectations of revenues, ... be the breakthrough year in which wearables begin to ... expected. One of the main reasons is the entrance ... not only the SmartWatches market, but the overall size ...
(Date:9/8/2015)... 8, 2015   TREW Marketing and ... Smart Marketing for Engineers TM : Content and ... reveals insightful findings about engineers, preferences for online content ... engineers most value and trust, and where they look ... technical audiences grapple with how to best implement online ...
(Date:9/2/2015)... September 2, 2015 ... implied in a system which uses identical human ... iris, vein, DNA and finger print. Increasing number ... develop such system which provides high level of ... Patterns and tokens are vulnerable to attacks. Furthermore, ...
Breaking Biology News(10 mins):
... blueprint of the rock pigeon, unlocking secrets about pigeons, Middle ... how mutations give pigeons traits like feather head crests. ... we know surprisingly little about their genetics," says Michael Shapiro, ... at the University of Utah. In the new study, ...
... and NEWTOWN, Pa., Jan. 31, 2013   Shareholder ... the acquisition of BioClinica, Inc. (NASDAQ: BIOC ... solutions to pharmaceutical, biotechnology, and medical device companies. ... On January 30, 2013, BioClinica announced that it had ...
... On January 30, 2013 ACS Nano published ... in the division of biomedical engineering at Brigham and ... that utilize nanotechnology to enhance the conductivity of materials ... cardiac patches put medicine a step closer to durable, ...
Cached Biology News:
... Blunt TOPO PCR Cloning ... designed for cloning and ... PCR products. The pCR4Blunt-TOPO ... Cloning and greater than ...
... 5 ml CELLection Dynabeads (4.5 m) coated ... epithelial antigen EpCAM and DNase Releasing Buffer. ... of epithelial tumour cells directly from blood, ... can be enriched from bone marrow. Enriched ...
Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera)...
Recombinant Human Erythropoietin (Tissue Culture Grade)...
Biology Products: